Consensus ABIONYX Pharma

Equities

ABNX

FR0012616852

Market Closed - Euronext Paris Other stock markets 09:56:32 2024-04-24 am EDT			5-day change	1st Jan Change
1.04 ^EUR	-1.52%		-4.94%	-19.25%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

e55b5f3b05bf132865b3cb5c.F2XhGcJhwFZGMJ-DSH3yrA9Fra_0xlt7nxhVgYczWB0.IRClaIgy7QI_CKm2ODfF6Fcxx-2xois-_VIz98RCG0hGXYdMsBXwAHdJxg~5b71551c4dcd1f294c50da641ca01971

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.04 EUR

Average target price

10.5 EUR

Spread / Average Target

+909.62%

High Price Target

10.5 EUR

Spread / Highest target

+909.62%

Low Price Target

10.5 EUR

Spread / Lowest Target

+909.62%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar